Science and innovation

Check out our news

Get our newsletters

Published on the 10 January 2017

Novel therapeuthic target against Ulcerative Colitis-Crohn disease in a mouse IBD model

Temperature sensitive anti-inflammatory Novel therapeuthic target against IBD Ulcerative colitis (UC) together with Crohn’s disease (CD), are Inflammatory bowel diseases (mouse IBD). The chronic and…

Science and innovation
Published on the 12 December 2016

Mouse ischemia reperfusion: a good preclinical model for myocardial infarction?

Myocardial infarction (MI) results from a biphasic ischemia/reperfusion (I/R) injury to the heart. The disease is linked to cardiomyocyte apoptosis and further along to inflammation-based tissue damag…

Science and innovation
Published on the 1 December 2016

Organ cross talk in DSS induced colitis can be effectively treated with anti-inflammatory molecule

Inflammatory bowel disease (IBD), consisting of Crohn’s disease (CD) and ulcerative colitis (UC), involves chronic inflammation of all or part of the digestive tract and millions are affected around t…

Science and innovation
Published on the 23 November 2016

Syncrosome sets up a new preclinical PAH (Pulmonary Arterial Hypertension) model in mouse.

Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial obstruction increases pulmonary vascular resistance, leading to right ventricular hypertrophy (RVH), failure, and death….

Science and innovation
Published on the 15 November 2016

Syncrosome keeps increasing its In vivo Preclinical skills

In the framework of our development, we are proud to announce the recruitment of our new scientific colleague, Guénaelle CANET. She will work in our Technical Department at the Lab and will …

Science and innovation
Published on the 11 November 2016

Parkinson 6 OHDA preclinical: New POC on rat to repair neurons, with new compound.

Researchers from the college of Pharmaceutical Sciences in China have recently studied a compound that enhances neuronal recovery in a rat model of Parkinson’s disease (Parkinson 6 OHDA). Parkinson’s…

Science and innovation
Published on the 7 November 2016

Evaluating preclinical emesis induced by PDE4 inhibitors via a noradrenergic pathway

Emesis and/or Nausea are commonly reported side effects associated with several drugs such as 4 phosphodiesterase (PDE4) inhibitors and is a major drawback for the therapeutic use of these drugs. The …

Science and innovation
Published on the 18 October 2016

Syncrosome at the 2nd DDIP in Munich

The 2nd Drug Discovery Innovation Programme will feature 2 days of interactive presentations, poster presentation and networking opportunity, in Hamburg (Germany) from 20 to 21st of October. This conf…

Science and innovation Events

Explore our scientific resources and browse posters…

Explore Our Resources